1. Home
  2. TCBI vs MMSI Comparison

TCBI vs MMSI Comparison

Compare TCBI & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TCBI

Texas Capital Bancshares Inc.

HOLD

Current Price

$100.74

Market Cap

3.9B

Sector

Finance

ML Signal

HOLD

MMSI

Merit Medical Systems Inc.

HOLD

Current Price

$68.05

Market Cap

4.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TCBI
MMSI
Founded
1996
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
4.0B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
TCBI
MMSI
Price
$100.74
$68.05
Analyst Decision
Hold
Strong Buy
Analyst Count
12
8
Target Price
$98.83
$100.38
AVG Volume (30 Days)
376.4K
709.8K
Earning Date
04-23-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
4.93
EPS
N/A
2.13
Revenue
N/A
$1,515,906,000.00
Revenue This Year
$14.76
$8.78
Revenue Next Year
$7.47
$5.76
P/E Ratio
$15.46
$32.19
Revenue Growth
N/A
11.75
52 Week Low
$61.38
$66.34
52 Week High
$108.92
$99.26

Technical Indicators

Market Signals
Indicator
TCBI
MMSI
Relative Strength Index (RSI) 65.08 39.87
Support Level $81.58 $66.76
Resistance Level $106.01 $71.57
Average True Range (ATR) 2.44 1.80
MACD 1.06 0.46
Stochastic Oscillator 87.41 34.62

Price Performance

Historical Comparison
TCBI
MMSI

About TCBI Texas Capital Bancshares Inc.

Texas Capital Bancshares Inc is a registered bank holding company and a full-service financial services firm that delivers customised solutions to businesses, entrepreneurs and individual customers. It is a secured lender with the majority of the loans held for investment, excluding mortgage finance loans and other national lines of business. Texas Capital has established commercial banking, consumer banking, investment banking and wealth management capabilities.

About MMSI Merit Medical Systems Inc.

Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.

Share on Social Networks: